🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

393,17 USD

Máx. histórico

447,03

14 días

Split 2:1 del 22/11/1999

Caída desde máximo

-12,05%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-10,08%

Cierre anterior

437,23

Rango de hoy

391,17 – 410,03

Volumen hoy

6.589.429

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
24,44 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 8 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,53%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/06/2005 60,40 60,44 59,64 59,84 -0,55% 1,32% 4.844.000
14/06/2005 60,01 60,50 59,50 60,17 +0,27% 1,67% 5.720.800
13/06/2005 60,35 60,60 59,94 60,01 -0,33% 1,09% 5.235.900
10/06/2005 60,41 60,53 59,90 60,21 -0,31% 1,04% 4.107.400
09/06/2005 60,15 60,99 59,95 60,40 +0,58% 1,73% 5.845.800
08/06/2005 60,15 60,62 59,90 60,05 -0,25% 1,20% 4.835.900
07/06/2005 61,08 61,27 59,88 60,20 -1,33% 2,28% 7.545.600
06/06/2005 61,40 62,05 61,00 61,01 -0,78% 1,71% 5.518.100
03/06/2005 62,95 63,04 61,32 61,49 -2,21% 2,73% 7.357.000
02/06/2005 63,13 63,17 62,62 62,88 -0,47% 0,87% 3.895.500
01/06/2005 62,95 63,51 62,70 63,18 +0,96% 1,29% 4.978.100
31/05/2005 62,72 62,98 62,58 62,58 -0,43% 0,64% 5.421.800
27/05/2005 62,74 63,00 62,56 62,85 +0,24% 0,70% 4.211.500
26/05/2005 62,51 62,78 62,07 62,70 +0,51% 1,14% 5.371.900
25/05/2005 62,50 62,54 62,11 62,38 -0,24% 0,69% 5.410.400
24/05/2005 62,55 63,01 62,04 62,53 +0,68% 1,55% 7.727.800
23/05/2005 61,61 62,19 61,42 62,11 +0,39% 1,25% 6.456.600
20/05/2005 62,04 62,33 61,57 61,87 +0,08% 1,23% 7.247.700
19/05/2005 62,41 62,50 61,48 61,82 -0,85% 1,63% 6.755.800
18/05/2005 62,86 62,90 62,16 62,35 -0,87% 1,18% 7.443.000
17/05/2005 62,70 63,00 62,24 62,90 -0,14% 1,21% 7.613.300
16/05/2005 61,94 63,01 61,90 62,99 +1,40% 1,79% 7.003.900
13/05/2005 61,68 62,49 61,49 62,12 +0,52% 1,62% 9.368.500
12/05/2005 61,25 62,04 61,20 61,80 +0,62% 1,37% 9.472.500
11/05/2005 61,03 61,50 60,37 61,42 +0,64% 1,85% 12.186.500
10/05/2005 59,90 61,77 59,80 61,03 +1,16% 3,29% 12.175.100
09/05/2005 58,75 60,35 58,71 60,33 +2,97% 2,79% 11.836.800
06/05/2005 59,09 59,21 58,32 58,59 -0,41% 1,51% 5.721.400
05/05/2005 58,73 58,97 58,30 58,83 -0,22% 1,14% 4.798.800
04/05/2005 58,68 59,00 58,38 58,96 +1,39% 1,06% 5.814.800